Vas Narasimhan, CEO Of Novartis: Transforming Standards Of Patient Care - Outside Lens
Committed to growing over 4% through 2026, says Novartis CEO
Novartis CEO Vas Narasimhan on M&a and Taking Earlier Risks on New Technology
Novartis agrees $9.7bn deal for US cholesterol drugmaker | Financial Times
Novartis's new chief sets sights on 'productivity revolution' | Financial Times
Vas Narasimhan: The American Trying To Reshape Novartis - WorldNewsEra
CNBC Halftime Report on Twitter: "Today on Halftime, don't miss @MegTirrell's #CNBCExclusive interview with Novartis CEO @VasNarasimhan! #JPM21 https://t.co/kmvOe2V4WJ" / Twitter
Digital transformation in the life sciences supply chain – show me the data | Kinaxis
News: Indian-origin Vasant Narasimhan appointed as the new CEO of Novartis — People Matters
Vas Narasimhan at the 2019 One Young World Summit - Human Engineers
The CEO of Swiss pharma giant Novartis voluntarily gave up $400,000 of his bonus, thanks to a controversy swirling around the world's most expensive drug | Business Insider India
Amazon.com: Victor Harrington: Books, Biography, Blog, Audiobooks, Kindle
Novartis CEO Cautions on Efficacy of Trump-Touted Covid-19 Treatment - TheStreet
A Year In, Novartis' Boss Faces The World
Johnson & Johnson chief figures Amazon could shake up pharma's distribution, rebates and more | Fierce Pharma
The 'student' of leadership who seeks to inspire his employees | Financial Times
novartis: Who is Vas Narasimhan? All about the new global chief executive of Swiss pharma giant Novartis - The Economic Times
Novartis's Vas Narasimhan on AI, Data Science for Company Operations
Amazon.com: Vasant Narasimhan: Books
Ousted Novartis scientist denies wrongdoing in data manipulation scandal - Super News
Novartis to acquire US-based cancer drugmaker Endocyte for $2.1 billion | Business Standard News